More lies and false info. Anyone with half a brain (obviously this excludes you) can view the financial reports and see what the OS is.
Thought you were all gone to Ocata yet here you remain posting the same BS as before. Remember what happened last time you were posting 24/7 about 201 failing? Should we revisit some of your lies? You are nothing but a penny flipper trying to get back in at a lower price and then flip for a few hundred dollars and you lie at every opportunity you can to achieve your little goal. What a truly pathetic existence you have.
I totally agree with your similarities. I bet if further research was done you woujld also see the same concerted effort from the shorts attacking the stock and MM's criminally manipulating the PPS until they got back on the Nasdaq. Elite is mirroring them IMO.
Elite employees are holding shares they bought at 2.75 years back. Do you really think the BOD is going to leave them holding the bag? Not a chance
Most already know this but for those that don't IB Stoopid is also Snupoled on IFLUB just using multiple ID's. With a name like IB Stoopid you would be prone to mistakes and of course IB made one on IFLUB many months back when he signed his Snupoled post ' IB :o)". What can you say? Once a DA always a DA and IB certainly is proof of that.
Sentiment: Strong Buy
All prior trials have been far exceeding required levels to prove Elites tech. This phase 3 is a small trial to measure naltrexone leakage. Elite was testing this years ago when you were still in the rice paddies. They know their tech works as advertised and there is no insiders dumping shares.
Guess you should get out now huh tool boy...remember all those posts you made calling the CEO a liar and the company a scam which I forwarded to the company but yet here you are day after day still here...makes a lot of sense huh tool boy
Yes waiting in dismal OTC land is hard but just focus on the companies every increasing fundamentals as you mention above and you will see the value increasing exponentially in your investment.
got Ocata? LOL.....nuff said on that one...... Squelshie do you honestly think Elite would have spent all these tens of million of dollars on research. phase trials, BE, HAL, patents, etc....if they did not thoroughly test their tech in house and prove it beyond any doubt first? 200, 201, 202, etc....it does not matter. It has been vetted and tested 1000 times over in house before we ever got to this point. It works as expected and stated by the company. If they decide to PR any results they will. They are not required to do so as material events but have typically done so in the past. Go on back to ocata and lose some more money for us so we can have a good laugh again about you over here.
Sure but over the past 9 months since we started seeing the insider moves such as converting and gifting their preferred stock, there has not been any significant insider sales. Yes, Epic had a small fractional amount of sales last year but the 2 primary persons from Epic currently own 87 million shares after their conversion. JT also converted his preferred stock and has sold none. These moves have been very spread and calculated in my opinion. If you google search warrants and converting, you will see the positive indicators it represents for us common holders. It basically means the insiders are assuming the same risk now that we are by holding common shares instead of preferred where they had insurance in case of any BK (not going to happen). They did not have to convert these warrants until the middle of next year yet chose to do it very early...why is that?...There is a plan in place and shortly we will all see it unveiled.
Merger Considerations: What happens to the warrants in the event the company is acquired? We can’t opine more strongly that all warrants should expire at a merger unless they are exercised just prior to the transaction. In other words, the warrant holder must decide to either exercise or give up the warrants if the company is acquired. Acquiring companies hate buying companies that have warrants survive a merger and allow the warrant holder to buy equity in the acquirer. Many a merger have been held up as warrants with this feature have upset the potential acquirer and thus as part of the closing requirements mandated that the company go out and repurchase and / or edit the terms of the warrants. This is not a good negotiating spot for the company to find itself in. It will have to pay off warrant holders while disclosing the potential merger (so the company will have little leverage) and at the same time will have a sword over its head by the acquirer until the issue is resolved.
Sentiment: Strong Buy
The timeline on the clinical website has not changed and is corroborated by the Camargo Director via email directly to me.
The Camargo Director in charge of the entire phase 3 trial for Elite said trial dosing begins in June. Pretty sure she is in the know and has the most up to date current info so few weeks to go